Tclarke Share Discussion Threads

[igoe104] 07/5/2024 18:35

Funds will except the deal. They have already consulted them before hand.

[geminian] 07/5/2024 17:24

Vote papers against, sent. Can only hope holders of enough shares decide to vote against. Probably too many for though.

[forensic] 07/5/2024 15:21

Voted against

[davebowler] 02/5/2024 17:26

IC view -
The exit multiple is hardly generous at 6.6 times earnings estimates and TClarke has net cash of £19.3mn, a sum equating to 21 per cent of the offer price. The fact that the final dividend of 4.5p is being paid is immaterial as it’s owed to shareholders for the 2023 financial year. I would vote against the scheme of arrangement.

[tiswas] 02/5/2024 10:29

The directors cash in a stack of options and presumably are being looked after by a long term major shareholder. I think they know exactly what they are doing, float it again in a few years time at double or treble the price and make a killing again.

[kneecaps2] 02/5/2024 10:04

Yes a very low bid. The directors must be insane to accept.

[18bt] 02/5/2024 07:35

I;m voting my shares against too.

[geminian] 01/5/2024 17:27

Having read an article on gg2.net where amongst other comments Deep Valecha says T Clarke is a well run company, my thoughts are that T Clarke is being sold off far too cheaply. While not holding enough shares to make any real difference, will be voting against the sale. Article found on Google search: Regent Gas Aquisitions - scroll down results to heading gg2.net - Deep Valecha’s Regent Group to acquire T Clarke for £90.56m - GG2

[petomi] 30/4/2024 17:00

I notice that Simon Thompson in the Inv Chronicle shares my view that quoting the historic P/E does not adequately reflect their prospects and thus serves to disguise the paucity of the offer:

"The acquirer states that the 160p-a-share take-out price equates to 11.6 times last year’s earnings per share (EPS), but it makes no reference to the fact that earnings were depressed. In fact, pre-tax profit is forecast to bounce back from £7.6mn to £17.1mn in 2024 to drive a 75 per cent rebound in EPS to 24.1p. The exit multiple is hardly generous at 6.6 times earnings estimates and TClarke has net cash of £19.3mn, a sum equating to 21 per cent of the offer price. The fact that the final dividend of 4.5p is being paid is immaterial as it’s owed to shareholders for the 2023 financial year. I would vote against the scheme of arrangement."

hxxps://www.investorschronicle.co.uk/ideas/2024/04/29/tclarke-s-cash-offer-is-easy-to-refuse/?xnpe_tifc=xuodbuP.4dQsbIojbdnlbMpsafeWaeiWhFW.RyPWVZ7DRuUcRdscVlBNEkscEkUZauUltu4vaMXDbuhuxFULhkesbDLuxkn8&utm_source=exponea&utm_campaign=IC%20-%20The%20Trader%20-%20Newsletter%2030.04.24&utm_medium=email

GLA

[tiswas] 25/4/2024 09:26

SO that is 3m odd of nil cost options that the directors can cash in if I am reading that right? Nearly £5m!

I had better not say what I am thinking!

[rivaldo] 23/4/2024 15:19

CTO ramping up the news flow this week. Let's hope it helps bring in more bidders....

Prestigious London contract win:



TClarke Healthcare tech in 80% + of all new UK scanning facilities:

[18bt] 19/4/2024 12:29

Now up to 2% and share price above offer price, so have they bought some more this morning? A number of sells at just above the offer price.

[bsdjj] 18/4/2024 08:08

I assume they are not there just to collect the 4.5p dividend......

[bsdjj] 17/4/2024 17:28

Someone bought 1.7%??

[janeann] 16/4/2024 15:28

well i first bought these in 2013 ..... at 62p, but very disappointed at todays price. bit of a rollercoaster ride but plenty of dividends on the way. A very sad day

[igoe104] 16/4/2024 13:08

Salpara, your moaning about a price of £1.60 for a takeover, but you and lots of others weren't interested in buying these in the mid 120s. 🤷

[dr biotech] 16/4/2024 12:46

Well I sold out last week after 2 years of underperformance. Impeccable timing. Seemed to be a vanity project with high turnover, low profits and fat director salaries. Much to my annoyance its seems another company sees value where I didn't

[salpara111] 16/4/2024 12:07

Watched this for some time but never took a stake.
I am amazed that the BOD are recommending this really poor premium when the share price was near a multi year low. The only conclusion one can reach is that current/forward prospects are not anywhere near as positive as the market has been led to believe.

[edmundshaw] 16/4/2024 08:56

Not entirely the fault of pension funds after Gordon Brown's raid on dividends...

Got to agree this is a poor price. Wincanton went for a fantastic premium after a second bid came along... so maybe worth sticking around?

[igoe104] 16/4/2024 08:49

Pension funds are to blame, uk Pension funds only invest 4% in there home market. Whilst overseas Pension funds invest 20% on average in there home market..

[owenski] 16/4/2024 08:39

This country has been a financial disaster since Brexit, Covid didn't help but either. Interestingly the people who moan about companies being bought out on the cheap - because there seems to be no investor appetite - are the ones who voted for it. Suck it up.

[petes5] 16/4/2024 08:34

Another one gone. Lots of research, numbers look good and then cannot understand why the price stays low. Then gets bought out cheap. There will be no companies left in the UK. Makes you think this is what the people in charge of the UK want.

[kneecaps2] 16/4/2024 08:29

I agree this is a very poor bid. T Clarke were trading at well above 160 in 2022 and only last month the directors were saying how bright the future was! I think they are worth over £2.